V019-8030 Screening compound: N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide

V019-8030 Screening compound: N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide
V019-8030 Screening compound: N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-8030
N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-8030

Molecular Formula

C29H27ClN4O3 (C29 H27 ClN4 O3)

Compound Name

N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide

IUPAC name

N-({[4-(4-chlorophenyl)-1-(3-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-cyclopropyl-2-phenylacetamide

SMILES

COc1cccc(-n2c(NC(CN(C3CC3)C(Cc3ccccc3)=O)=O)nc(-c(cc3)ccc3Cl)c2)c1

InChI

InChI=1S/C29H27ClN4O3/c1-37-25-9-5-8-24(17-25)34-18-26(21-10-12-22(30)13-11-21)31-29(34)32-27(35)19-33(23-14-15-23)28(36)16-20-6-3-2-4-7-20/h2-13,17-18,23H,14-16,19H2,1H3,(H,31,32,35)

InChI Key

UDIAVAVSVAWHNP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825698

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

515.01

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.249

Distribution Coefficient, logD

6.249

Water Solubility, LogSw

-6.23

Polar Surface Area

58.985

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

2.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.70

V019-8030 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V019-8030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-8030?
Check Price and Availability of V019-8030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-8030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-8030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-8030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-8030 available by request